Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 15th, there was short interest totalling 57,300 shares, a drop of 9.0% from the July 31st total of 63,000 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average daily trading volume, of 32,300 shares, the short-interest ratio is currently 1.8 days.
Cocrystal Pharma Stock Down 3.3 %
Shares of COCP traded down $0.06 during mid-day trading on Tuesday, hitting $1.74. The stock had a trading volume of 17,311 shares, compared to its average volume of 22,127. Cocrystal Pharma has a fifty-two week low of $1.33 and a fifty-two week high of $3.10. The company has a market cap of $17.70 million, a PE ratio of -1.00 and a beta of 1.41. The company’s fifty day simple moving average is $2.08 and its two-hundred day simple moving average is $1.88.
Cocrystal Pharma (NASDAQ:COCP – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.51) by ($0.02). Equities analysts expect that Cocrystal Pharma will post -1.94 earnings per share for the current year.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on COCP
About Cocrystal Pharma
Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.
Further Reading
- Five stocks we like better than Cocrystal Pharma
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Small Cap Stocks That Insiders Are Buying
- Why Invest in 5G? How to Invest in 5G Stocks
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Must-Own Stocks for Bullish Investors in Today’s Market
Receive News & Ratings for Cocrystal Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cocrystal Pharma and related companies with MarketBeat.com's FREE daily email newsletter.